Form 4: MaxCyte CFO Sells Shares for Tax Obligations

MaxCyte's Chief Financial Officer, Douglas J. Swirsky, sold 10,142 shares of common stock to cover tax withholding obligations related to RSU vesting.

Summary

• Douglas J. Swirsky, Chief Financial Officer of MaxCyte, Inc. (MXCT), reported a sale of 10,142 shares of common stock.
• The transaction occurred on March 17, 2026, at a weighted average price of $0.815 per share.
• The sale was non-discretionary, executed solely to cover tax withholding due upon the vesting of previously granted restricted stock units (RSUs).
• Following this transaction, Mr. Swirsky beneficially owns 151,669 shares of MaxCyte common stock.
• The shares were sold in multiple transactions at prices ranging from $0.783 to $0.825, inclusive.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The transaction is a non-discretionary sale for tax purposes, which is a standard practice and does not indicate a change in the company's fundamentals or insider sentiment.

Positives

• The sale was explicitly stated as a 'sale to cover' tax withholding obligations, indicating it was not a discretionary trade based on insider sentiment regarding the company's future.

Negatives

• A reduction in direct insider ownership, even for tax purposes, represents a slight decrease in the direct alignment of the officer's personal holdings with shareholder interests.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

StockSavvy.ai notes that 'sale to cover' transactions are a common and routine occurrence for executives receiving equity compensation. They are typically pre-arranged and executed to satisfy tax obligations upon the vesting of restricted stock units, and generally do not reflect a discretionary investment decision or a change in management's outlook on the company's prospects.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in company fundamentals or insider confidence.

Key Dates

Keywords

MAXCYTE, MXCT, Form 4, Insider Transaction, Stock Sale, RSU Vesting, Tax Withholding, Douglas J. Swirsky, CFO